market
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
market | 23 May 2012
-
Pharmaceutical giants set to lose dominance in urological disorders market
Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a report by GBI Research has found.
market | 17 May 2012
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
market | 27 April 2012
-
Refinements in inhaled drug delivery enhances growth prospects as global markets emerge
Survey finds evolving device technologies creating opportunities for drug developers, according to Greystone Research Associates.
market | 10 April 2012
-
Biosimilars provide cost saving to users, industry
Biosimilars provide significant cost saving to both the users and the industry hence the adoption of these drugs are expected to be higher side.
market | 24 February 2012
-
Phosphagenics licenses Diclofenac gel for Indian market
Phosphagenics has licensed TPM/diclofenac, its topical non-steroidal pain formulation, to Themis Medicare of Mumbai for the Indian market. This represents Phosphagenics’ first commercial deal in India and its first licensing agreement of its diclofenac product. Under the terms of the agreement, Themis Medicare is committed to pay Phosphagenics an undisclosed up-front fee and double-digit royalty payments on sales.
market | 06 January 2012
-
Takeda appoints Jostein Davidsen Head of Emerging Markets
Nycomed's presence in Emerging Markets was a key driver for Takeda to acquire Nycomed at the end of September 2011.
market | 17 October 2011
-
Nycomed and Almirall announce a licensing agreement for ebastine in China and other key Southeast Asia markets
• With this agreement, Almirall extends the global reach of the product, present now in more than 30 countries worldwide.
market | 29 September 2011
-
Charles River selects BRASS to market biopharmaceutical services in Singapore
Charles River announces that it has entered into a marketing agreement with Singapore-based Biomedical Research And Support Services Pte. Ltd (BRASS). Through the agreement, BRASS will market within Singapore, Malaysia, Indonesia, and Vietnam the wor…
market | 15 August 2011
-
Nutra Pharma receives regulatory approval to market Nyloxin in India
Nutra Pharma has received approval in India for its Nyloxin line of pain relievers.
market | 11 August 2011
